Stocks Slide as Iran War Uncertainty Grows; Tesla, Coinbase and Oil Markets React

Wall Street retreated Thursday as investors grappled with escalating geopolitical risks tied to the ongoing conflict between the U.S. and Iran, while corporate earnings and regulatory milestones added volatility to trading. The Dow Jones Industrial Average slipped 61.07 points, or 0.13%, to 46,504.67, snapping a two-day winning streak, while the S&P 500 and Nasdaq Composite eked out modest gains of 0.11% and 0.18%, respectively. Oil prices surged past $110 per barrel, stoking inflation worries and pressuring consumer sentiment.

Geopolitical Tensions With Iran Fuel Market Uncertainty

The U.S. stock market’s fragile rebound from Wednesday’s gains was quickly undone by renewed concerns over the duration and intensity of military operations in the Middle East. Speaking from the White House on Wednesday, President Donald Trump indicated that U.S. strikes against Iranian-backed forces could persist for two or three more weeks—a timeline that, while shorter than feared, still injected fresh volatility into equities.

Investors Seek Clarity Amid Hawkish Rhetoric

Larry Tentarelli, chief technical strategist at the Blue Chip Daily Trend Report, noted that markets often respond positively to any semblance of certainty, even if the underlying news is negative. ‘What often happens with the stock market is that any certainty is often considered a positive,’ Tentarelli told CNBC. ‘There looks to be light at the end of the tunnel.’ His remarks underscored the delicate balance investors are striking between geopolitical risk and the hope that a defined conflict timeline could prevent prolonged disruption.

Oil Prices Spike on Supply Disruption Fears

The prospect of prolonged military engagement in the region sent crude oil futures soaring. West Texas Intermediate (WTI) crude, the U.S. benchmark, climbed above $110 per barrel for the first time in months, reflecting concerns over potential supply disruptions from key Middle Eastern producers. Analysts warned that sustained high energy prices could exacerbate inflationary pressures, complicating the Federal Reserve’s path to monetary policy normalization. ‘Energy is the first domino to fall in inflation expectations,’ said a senior strategist at a major investment bank, who requested anonymity.

Tesla Shares Drop as EV Delivery Growth Slows

Electric vehicle leader Tesla reported a 6% year-over-year increase in first-quarter vehicle deliveries, totaling 358,023 units—a figure that nonetheless fell short of some investors’ expectations. Production also dipped 14% from the prior quarter to 408,386 vehicles, as the company reallocated resources at its Fremont, California, factory to prioritize development of its Optimus humanoid robot. Analysts at Wedbush described the results as ‘underwhelming’ given the broader challenges facing the EV sector across global markets.

Strategic Shift Raises Questions About Core Business Focus

Tesla’s pivot toward AI and robotics, including the temporary shutdown of its Model S and X production lines, signals a deliberate shift away from traditional automotive manufacturing. ‘This was not a shock to us given the current EV backdrop across geographies while the company shifts gears to focus more on its AI strategy,’ said Dan Ives, managing director at Wedbush. Investors will look for further clarity on the company’s long-term strategy during its April 22 earnings call, particularly regarding the commercial viability of its AI initiatives.

Coinbase Gains Regulatory Leverage with OCC Trust Charter

Amid the market turbulence, Coinbase secured a conditional approval from the U.S. Office of the Comptroller of the Currency (OCC) to operate as a federally regulated trust bank—a move that could significantly expand its payment and custody services. The crypto exchange will retain its core business model without becoming a commercial bank, but the charter grants it access to critical banking infrastructure and regulatory credibility.

Over the long haul we will be able to explore, with the OCC, offering not just custody products but also other infrastructure products, particularly around payments, that we think will expand and extend crypto payments in all sorts of new and interesting and important directions.

How the Trust Charter Could Reshape Crypto Payments

Paul Grewal, Coinbase’s chief legal officer, emphasized that the approval is a stepping stone toward integrating crypto payments into mainstream financial systems. While Coinbase will not accept retail deposits or engage in fractional reserve banking, the trust charter positions it to compete more directly with traditional payment processors like PayPal and Square. The move comes as regulators increasingly scrutinize stablecoin issuers, with the OCC signaling a willingness to provide clearer frameworks for crypto-native financial services.

S&P 500 Shows Mixed Performance Amid Sector Rotations

The broader market painted a mixed picture Thursday, with 11 S&P 500 components hitting 52-week lows while five reached new highs. The divergence highlighted shifting investor sentiment, with defensive sectors like utilities and healthcare outperforming but cyclical industries—including housing and consumer discretionary—facing pressure.

Defensive Sectors Hold Up as Cyclicals Lag

Among the hardest-hit stocks were Lennar (down to December 2022 lows), Global Payments (trading at 2016 levels), and Nike (near October 2014 troughs). Conversely, utility giant Sempra hit an all-time high, reflecting its status as a defensive play during periods of uncertainty. Healthcare names like Pfizer also posted gains, while Entergy and Equinix reached historic peaks, underscoring the market’s bifurcated performance.

Apollo Economist Downplays AI’s Immediate Labor Market Impact

As the market digested corporate earnings and geopolitical headlines, Torsten Slok, chief economist at Apollo Global Management, pushed back on concerns that artificial intelligence is already reshaping the labor market. Speaking on CNBC’s ‘Squawk on the Street,’ Slok acknowledged that while unemployment rates for young adults have risen, the trend aligns with broader economic conditions rather than AI-driven displacement.

White-Collar Job Cuts Raise Broader Questions

Slok’s comments followed reports that Oracle is cutting thousands of jobs as it redirects resources toward AI investments—a pattern seen across the tech sector. ‘What we're waiting for is to begin to see the impact of AI really broadly in the economy,’ Slok said. His remarks precede Friday’s closely watched U.S. jobs report, which may provide further insight into whether AI is contributing to structural shifts in employment.

Key Takeaways: What Investors Need to Know

• The Dow Jones fell 0.13% as Middle East tensions weighed on investor sentiment, while oil prices surged past $110 per barrel, threatening to reignite inflation concerns.
• Tesla’s Q1 deliveries grew 6% year-over-year but declined 14% quarter-over-quarter, as the company pivoted toward AI and robotics, sending shares down over 5%.
• Coinbase received conditional OCC approval to operate as a trust bank, a move that could expand its payment infrastructure while maintaining its crypto-native business model.
• The S&P 500 showed stark sector divergence, with 11 stocks hitting 52-week lows (including Lennar and Nike) while five reached new highs (including Entergy and Sempra).
• Apollo’s chief economist downplayed AI’s immediate impact on labor markets, despite recent white-collar layoffs at companies like Oracle.

White House Eyes 100% Tariff on Patent Drugs in Trade Crackdown

In a separate but equally consequential development, the Trump administration is drafting a policy to impose a 100% tariff on patented drugs and related ingredients manufactured by companies that have not entered into pricing agreements with the federal government. The measure, which could be enacted as soon as Thursday, aims to curb rising pharmaceutical costs but includes exemptions for generic and orphan drugs.

Industry Response and Potential Market Impact

More than a dozen major drugmakers, including Eli Lilly, Pfizer, and Johnson & Johnson, have already negotiated deals to avoid the tariffs. The policy reflects the administration’s broader push to lower healthcare costs through trade measures, though critics warn it could disrupt supply chains and reduce access to critical medications. The pharmaceutical sector, which has outperformed the broader market this year, now faces heightened regulatory risk.

Frequently Asked Questions